New players, new strategies, new resolve raise NIH budget to new level March 30, 2018Vol.44 No.13By Matthew Bin Han Ong
Drugs & Targets Novartis’s Tasigna approved for children with rare form of leukemia March 23, 2018Vol.44 No.12
Drugs & Targets FDA approves Adcetris for adults with previously untreated stage III or IV classical Hodgkin lymphoma March 23, 2018Vol.44 No.12
Drugs & Targets University of Maryland certified for CAR T-cell therapy in lymphoma March 23, 2018Vol.44 No.12
Clinical Roundup BioPharma publishes phase III COLUMBUS data of encorafenib and binimetinib March 23, 2018Vol.44 No.12
Clinical Roundup AVEO Oncology publishes long-term follow-up results from TIVO-1 Extension Study in TKI refractory RCC March 23, 2018Vol.44 No.12
Clinical Roundup Finasteride shown to prevent prostate cancer for up to 16 years March 23, 2018Vol.44 No.12
Clinical Roundup Machines see the future of patients diagnosed with brain tumors March 23, 2018Vol.44 No.12
